National Cancer Center, Korea
Clinical trials sponsored by National Cancer Center, Korea, explained in plain language.
-
New hope for liver cancer patients who Can't have surgery?
Disease control Not yet recruitingThis study tests the drug lenvatinib as the first treatment for people with advanced liver cancer who cannot have surgery or other curative treatments. It includes 50 adults with a specific type of liver function (Child-Pugh B). The goal is to see if lenvatinib can slow cancer gr…
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Exercise may soothe Chemo's nerve pain, new trial hopes
Symptom relief Not yet recruitingThis study tests whether exercise can reduce nerve damage caused by chemotherapy drugs like oxaliplatin and paclitaxel. About 140 people with colorectal or gynecologic cancer will either exercise or receive usual care. Researchers will check nerve function, blood markers, and qua…
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC